Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 53 citing articles:

The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa
Julio Rosenstock, Rattan Juneja, John M. Beals, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 3, pp. 379-413
Open Access | Times Cited: 30
Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial
Richard M. Bergenstal, Ruth S. Weinstock, Chantal Mathieu, et al.
The Lancet (2024) Vol. 404, Iss. 10458, pp. 1132-1142
Closed Access | Times Cited: 12
Continuous Glucose Monitoring–Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4
Harpreet S. Bajaj, Björg Ásbjörnsdóttir, Lisbeth Carstensen, et al.
Diabetes Care (2024) Vol. 47, Iss. 4, pp. 729-738
Open Access | Times Cited: 10
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes
Roberto Trevisan, Matteo Conti, Stefano Ciardullo
Diabetologia (2024) Vol. 67, Iss. 8, pp. 1480-1492
Open Access | Times Cited: 10
Current barriers to initiating insulin therapy in individuals with type 2 diabetes
Alba Galdón Sanz-Pastor, Alicia Justel Enríquez, Ana Sánchez Bao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial
Ildiko Lingvay, Malik Benamar, Liming Chen, et al.
Diabetologia (2025)
Open Access | Times Cited: 1
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes
Eda Cengiz, Thomas Danne, Tariq Ahmad, et al.
Hormone Research in Paediatrics (2025), pp. 619-649
Closed Access | Times Cited: 1
Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 1 diabetes
Ulrike Hövelmann, Susanne Engberg, Tim Heise, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 5, pp. 1941-1949
Open Access | Times Cited: 7
Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials
Mushood Ahmed, Aimen Shafiq, Hira Javaid, et al.
Endocrinology Diabetes & Metabolism (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 4
Understanding the Pharmacokinetics and Glucodynamics of Once Weekly Basal Insulins to Inform Dosing Principles: An Introduction to Clinicians
Thomas R. Pieber, Jennifer Leohr, Juliana Bue‐Valleskey, et al.
Endocrine Practice (2024) Vol. 30, Iss. 9, pp. 863-869
Open Access | Times Cited: 4
Insulin Icodec: First Approval
Hannah A. Blair
BioDrugs (2024) Vol. 38, Iss. 5, pp. 717-724
Closed Access | Times Cited: 4
Weekly injectable insulin icodec for adults with diabetes
Sooyoun Shin, Catherine Yu
Canadian Medical Association Journal (2025) Vol. 197, Iss. 2, pp. E44-E44
Open Access
Pharmacotherapy of type 1 diabetes - part 1: yesterday
Marc Rendell
Expert Opinion on Pharmacotherapy (2025), pp. 1-12
Closed Access
Perioperative and periprocedural management of once-weekly insulin treated patients
Robyn L. Houlden, Jeremy Gilbert, Tayyab Khan, et al.
Endocrine Practice (2025)
Closed Access
Once-Weekly Insulins
J. Hans DeVries, Tim Heise
Diabetes Technology & Therapeutics (2025)
Closed Access
No evidence of increased hypoglycaemia attributed to physical activity with once‐weekly insulin icodec versus once‐daily basal insulin degludec in type 1 diabetes: A post hoc analysis of ONWARDS 6
Harald Sourij, Richard M. Bracken, Lisbeth Carstensen, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Once-Weekly Insulin Icodec Versus Once-Daily Insulin Degludec in Insulin-Naive Chinese Participants with Type 2 Diabetes: A Post Hoc Analysis of ONWARDS 3
Yijun Li, Soumitra Kar, Congcong Li, et al.
Diabetes Therapy (2025)
Open Access
New Insulins, Biosimilars, and Insulin Therapy
Torben Biester, Lutz Heinemann
Diabetes Technology & Therapeutics (2025) Vol. 27, Iss. S1, pp. S41-S63
Closed Access
Design of a novel long-acting insulin analogs by acetylation modification and compared with insulin Icodec
Min Yu, Chao Zhang, Hongjiang Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Glycemic Management Across the Lifespan for People With Type 1 Diabetes: A Clinical Practice Guideline
Ilana Halperin, Brandy Wicklow, Shazhan Amed, et al.
Canadian Journal of Diabetes (2025) Vol. 49, Iss. 1, pp. 5-18
Closed Access
Pourquoi la variabilité glycémique est-elle si importante dans le risque d’hypoglycémie iatrogène : de la théorie à la pratique
L. Monnier, C Colette, Éric Renard, et al.
Médecine des Maladies Métaboliques (2025)
Closed Access
Preferences, Expectations and Attitudes on Basal Insulin from Patient–Physician–Payer Perspective: A Multi-stakeholder Survey by the Italian Diabetes Society (ITA4P Study)
Gian Paolo Fadini, Stefano Ciardullo, Gianluca Perseghin, et al.
Diabetes Therapy (2025)
Open Access
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus
David Q. Pham, John Andraos, Joelle Ayoub
Reviews in Endocrine and Metabolic Disorders (2025)
Open Access
Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
Obieda Altobaishat, Ahmed Farid Gadelmawla, Suliman Almohtasib, et al.
Endocrinology Diabetes & Metabolism (2025) Vol. 8, Iss. 3
Open Access
Insulin resistance in type 2 diabetes mellitus
Domenico Accili, Zhihui Deng, Qingli Liu
Nature Reviews Endocrinology (2025)
Closed Access
Page 1 - Next Page

Scroll to top